Holi, a Polish HealthTech startup constructing a digital weight problems clinic, has raised €3 million in Seed funding to enter new European markets and additional develop its data-driven care platform.
The spherical led by 4growth VC (Poland) with participation from YZR Capital (Germany), Heartfelt Capital (Germany) and a bunch of enterprise angels.
“Weight problems therapy requires continuity and the mixing of a number of medical competencies,” says Paweł Seweryn, Founder & CEO of Holi. “Our aim is to ship a complete resolution that results in actual, long-term change in metabolic well being. The funding will allow us to scale our mannequin internationally – beginning with the Southern and Jap Europe markets, that are extremely receptive to non-public healthcare and telemedicine – whereas additional creating our know-how stack.”
Holi’s Seed spherical situates the corporate inside a visibly lively 2025 European HealthTech and digital obesity-care panorama. A number of friends have additionally attracted capital this yr:
-
Numan (UK, London) raised €51.6 million to increase its preventative digital-health platform, which incorporates weight problems and hormonal well being administration.
-
Doctor.One (Poland, Warsaw) secured €4 million to develop its asynchronous chronic-care mannequin – overlaying weight problems amongst different circumstances – into Western European markets.
-
Ciloa (France, Montpellier) obtained €6.5 million to progress exosome-based therapies focusing on metabolic illnesses similar to weight problems and kind 2 diabetes.
Collectively, these examples illustrate growing investor consideration to weight problems therapy and metabolic-care innovation. The truth that one other Polish startup, Physician.One, raised funds in the identical yr highlights Poland’s rising presence in European digital healthcare.
EU-Startups beforehand lined Holi’s €680k pre-Seed round in 2023, underscoring its early traction within the area. Inside this context, Holi’s new funding displays a gradual development from proof-of-concept towards regional scale-up – aligned with broader 2025 traits in hybrid, data-driven fashions for metabolic well being administration.
“The following era of weight problems therapy will likely be hybrid – information and AI for precision, consultants for influence. Our platform repeatedly analyses affected person information to regulate remedy in actual time, whereas docs and specialists step in precisely when human intervention issues most. That’s how we ship higher outcomes with smarter use of remedy,” explains Jan Kundziołka, Co-founder of Holi, chargeable for product and know-how.
Based in 2023, Holi is a digital weight problems clinic that mixes multidisciplinary medical care (docs, psychodietitians, psychologists, physiotherapists) with know-how that helps way of life change and pharmacotherapy.
It additionally offers entry to GLP-1-based pharmacotherapy, together with medicine similar to Ozempic and Wegovy.
Via its cell app and specialist platform, Holi goals to ship personalised therapy plans and steady affected person monitoring. It operates on a subscription-based mannequin and focuses on bettering metabolic well being by treating the basis causes – not simply the signs – of weight problems.
The funds will likely be allotted to scaling Holi’s medical infrastructure and enhancing its know-how capabilities, together with diagnostics integration, GLP-1 monitoring, automation of care processes and new engagement options designed to maintain affected person motivation over time.
In keeping with information supplied by the corporate, sufferers utilizing the platform obtain on common a 17% discount in physique weight after 12 months – round 1.5x greater than pharmacotherapy alone. By combining data-driven dose optimisation with behavioural teaching, Holi reprotedly helps sufferers lower their remedy prices by as much as 50%.
In keeping with WHO information, greater than 800 million individuals worldwide are presently dwelling with weight problems, and practically two billion are obese. Weight problems is now labeled as one of many largest international public well being challenges, contributing to greater than 200 medical circumstances and driving growing strain on healthcare methods.
“Weight problems stays some of the underserved well being wants globally. Holi has constructed a really environment friendly care mannequin – digital, scalable and designed with a real value-for-money mindset. It delivers clinically confirmed outcomes at a value level that is smart for each sufferers and the enterprise. This mix of medical influence and sensible product design is strictly what satisfied us to take a position,” says Krzysztof Bachta, Managing Companion at 4growth VC.
The EU weight problems therapy market is estimated at €40-50 billion, with personal healthcare spending rising quickly as GLP-1 medicine similar to Ozempic, Wegovy and Mounjaro change into extra extensively adopted by sufferers.
“Since our preliminary funding, Holi has proven exceptional progress – each in scientific outcomes and operational execution. The corporate is scaling quick whereas sustaining sturdy medical requirements, which is uncommon on this market. That’s precisely why we determined to considerably enhance our backing on this spherical,” says Markus Feuerecker, Co-founder and Managing Companion at YZR Capital.
